Skip to content

Clinical trials

Observational Carpal Tunnel Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carpal Tunnel Syndrome Phase: Observational Clear all

133 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20061
20071
20081
20092
20102
20113
20122
20132
20144
20153
20169
20172
20181
20197
20208
202112
20227
202321
202414
202513
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed69
Unknown status23
Recruiting15
Not yet recruiting10
Withdrawn5
Terminated4
Enrolling by invitation4
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ahram Canadian University7
Beylikduzu State Hospital4
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey4
Ankara Training and Research Hospital3
Kutahya Health Sciences University3
Riphah International University3
Skane University Hospital3
Stanford University3
Bezmialem Vakif University2
Hasan Kalyoncu University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carpal Tunnel Syndrome133
Median Neuropathy11
Disease5
Pain5
Nerve Compression Syndromes4
Peripheral Nervous System Diseases4
Amyloid Neuropathies, Familial3
Amyloidosis3
Arthritis, Rheumatoid3
Chronic Pain3

Trials

Showing 1 to 25 of 133. Each trial links to its page on Pharma Observatory.

33 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.